Venlafaxine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

86 API Suppliers, 43 USDMF, 45 CEP/COS, 3 JDMF, 24 EU WC, 6 KDMF, 19 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

456 FDF Dossiers, 177 FDA Orange Book, 199 Europe, 48 Canada, 7 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 150MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 75MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 3 Rochem International Inc, 19 SPI Pharma, 2 Seqens, 10 DKSH, 3 Jai Radhe Sales, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 14 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 39 BASF, 2 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 25 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 4 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

104 Fillers, Diluents & Binders, 72 Coating Systems & Additives, 50 Direct Compression, 46 Disintegrants & Superdisintegrants, 45 Controlled & Modified Release, 43 Thickeners and Stabilizers, 38 Solubilizers, 33 Granulation, 29 Topical, 29 Taste Masking, 25 Lubricants & Glidants, 23 Film Formers & Plasticizers, 22 Parenteral, 22 Co-Processed Excipients, 20 Chewable & Orodispersible Aids, 12 Emulsifying Agents, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 26 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 32 Finished Drug Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

16 Health Canada Patents

16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22104 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
VENLAFAXINE HYDROCHLORIDE(UNII: 7D7RX5A8MO) (VENLAFAXINE - UNII:GRZ5RCB1QG)	VENLAFAXINE	75mg

Inactive Ingredients

Ingredient Name	Bryant Ranch Prepack	Chartwell RX, LLC	Edenbridge Pharmaceuticals LLC.	Lannett Company, Inc.	Ascent Pharmaceuticals, Inc.	BluePoint Laboratories	Camber Pharmaceuticals, Inc.	REMEDYREPACK INC.	UCB, Inc.	Upstate Pharma, LLC	XLCare Pharmaceuticals, Inc.	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	Sun Pharma Global Inc.
CARNAUBA WAX(R12CBM0EIZ)
CELLULOSE ACETATE(3J2P07GVB6)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSPOVIDONE (120 .MU.M)(68401960MK)
CROSPOVIDONE(68401960MK)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE(O7TSZ97GEP)
DIBUTYL SEBACATE(4W5IH7FLNY)
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER (2:1; 600000 MW)(XRK36F13ZZ)
FD&C BLUE NO. 1(H3R47K3TBD)
FD&C RED NO. 40(WZB9127XOA)
ferrosoferric oxide(XM0M87F357)
HYPROMELLOSE 2208 (4000 MPA.S)(39J80LT57T)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
LACTOSE(J2B2A4N98G)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
MANNITOL(3OWL53L36A)
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A(NX76LV5T8J)
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER(NX76LV5T8J)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL 3350(G2M7P15E5P)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYETHYLENE GLYCOL 8000(Q662QK8M3B)
POLYETHYLENE GLYCOL(3WJQ0SDW1A)
polyethylene glycol, unspecified(3WJQ0SDW1A)
POLYSORBATE 20(7T1F30V5YH)
POLYSORBATE 80(6OZP39ZG8H)
POLYVINYL ACETATE(32K497ZK2U)
POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER (3:1; 45000 MW)(23ZQ42JZZH)
POLYVINYL ALCOHOL(532B59J990)
POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990)
POVIDONE K30(U725QWY32X)
POVIDONE(FZ989GH94E)
POVIDONE, UNSPECIFIED(FZ989GH94E)
PROPYLENE GLYCOL(6DC9Q167V3)
silicon dioxide(ETJ7Z6XBU4)
SODIUM LAURYL SULFATE(368GB5141J)
STEARETH-20(L0Q8IK9E08)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)
triacetin(XHX3C3X673)
TRIETHYL CITRATE(8Z96QXD6UM)
WATER(059QF0KO0R)

Drug Product Composition: Venlafaxine Hydrochloride